The Europe Microwave Ablation Market should witness market growth of 13.6% CAGR during the forecast period (2022-2028).
Microwave ablation technology is expected to gain profitable revenue share in the near future. The use of microwave ablation technology in the tissues having poor electrical conductivity, such as lungs & bones, could be effective. Some of the critical advantages of microwave ablation technology are less pain during ablation, effective heating of cystic mass, and large tumor ablation volumes. The demand for this technology is growing as a result of the rising preference of patients to undergo procedures that require less time, shorter hospital stays, and fewer issues associated with them.
Ablative technologies are crucial in local and regional therapies for patients who cannot undergo surgeries. Heat technologies such as micro are used to control & treat tumors in various organs. Microwave ablation has emerged as a successful technology as it could also overcome the inefficiencies of radiofrequency ablation, such as low conductivity.
MWA is an energy-based thermal technique that results in cellular death by using coagulative necrosis through dipole & iconic mechanisms. Though the technique is quite similar to radiofrequency ablation technology, various clinical applications have resulted in finding advantages of microwave ablation over RFA.
The medical device industry in Germany is one of the most lucrative in the European market, with annual revenue of over USD 35.8 billion. This well-established medical equipment industry in the region enables the healthcare industry to have easy access to advanced medical technologies & equipment, such as microwave ablation antennae. Besides this, the favorable attitude of the region’s government toward the development of the healthcare sector further attracts the market players to enter the regional market and provide innovative technologies. This would support the growth of the regional microwave ablation market.
The Germany market dominated the Europe Microwave Ablation Market by Country in 2021; thereby, achieving a market value of $46,206 Thousands by 2028. The UK market is exhibiting a CAGR of 12.7% during (2022-2028). Additionally, The France market would experience a CAGR of 14.4% during (2022-2028).
Based on End-user, the market is segmented into Hospital, Research Laboratories, and Ambulatory Surgical Centers. Based on Component, the market is segmented into Accessories, Generator, and Power Distribution System. Based on Application, the market is segmented into Oncology, Cardiology, Urology, Orthopedic, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Varian Medical Systems, Inc. (Siemens Healthineers AG), AngioDynamics, Inc., Medtronic PLC, Johnson & Johnson (Johnson & Johnson Services, Inc.), Terumo Corporation, Emblation Limited, HUBER+SUHNER AG, MedWaves, Inc., SympleSurgical, Inc. and Mermaid Medical Group.
Microwave ablation technology is expected to gain profitable revenue share in the near future. The use of microwave ablation technology in the tissues having poor electrical conductivity, such as lungs & bones, could be effective. Some of the critical advantages of microwave ablation technology are less pain during ablation, effective heating of cystic mass, and large tumor ablation volumes. The demand for this technology is growing as a result of the rising preference of patients to undergo procedures that require less time, shorter hospital stays, and fewer issues associated with them.
Ablative technologies are crucial in local and regional therapies for patients who cannot undergo surgeries. Heat technologies such as micro are used to control & treat tumors in various organs. Microwave ablation has emerged as a successful technology as it could also overcome the inefficiencies of radiofrequency ablation, such as low conductivity.
MWA is an energy-based thermal technique that results in cellular death by using coagulative necrosis through dipole & iconic mechanisms. Though the technique is quite similar to radiofrequency ablation technology, various clinical applications have resulted in finding advantages of microwave ablation over RFA.
The medical device industry in Germany is one of the most lucrative in the European market, with annual revenue of over USD 35.8 billion. This well-established medical equipment industry in the region enables the healthcare industry to have easy access to advanced medical technologies & equipment, such as microwave ablation antennae. Besides this, the favorable attitude of the region’s government toward the development of the healthcare sector further attracts the market players to enter the regional market and provide innovative technologies. This would support the growth of the regional microwave ablation market.
The Germany market dominated the Europe Microwave Ablation Market by Country in 2021; thereby, achieving a market value of $46,206 Thousands by 2028. The UK market is exhibiting a CAGR of 12.7% during (2022-2028). Additionally, The France market would experience a CAGR of 14.4% during (2022-2028).
Based on End-user, the market is segmented into Hospital, Research Laboratories, and Ambulatory Surgical Centers. Based on Component, the market is segmented into Accessories, Generator, and Power Distribution System. Based on Application, the market is segmented into Oncology, Cardiology, Urology, Orthopedic, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Varian Medical Systems, Inc. (Siemens Healthineers AG), AngioDynamics, Inc., Medtronic PLC, Johnson & Johnson (Johnson & Johnson Services, Inc.), Terumo Corporation, Emblation Limited, HUBER+SUHNER AG, MedWaves, Inc., SympleSurgical, Inc. and Mermaid Medical Group.
Scope of the Study
By End-user
- Hospital
- Research Laboratories
- Ambulatory Surgical Centers
By Component
- Accessories
- Generator
- Power Distribution System
By Application
- Oncology
- Cardiology
- Urology
- Orthopedic
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Varian Medical Systems, Inc. (Siemens Healthineers AG)
- AngioDynamics, Inc.
- Medtronic PLC
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Terumo Corporation
- Emblation Limited
- HUBER+SUHNER AG
- MedWaves, Inc.
- SympleSurgical, Inc.
- Mermaid Medical Group
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Europe Microwave Ablation Market by End-user
Chapter 5. Europe Microwave Ablation Market by Component
Chapter 6. Europe Microwave Ablation Market by Application
Chapter 7. Europe Microwave Ablation Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Varian Medical Systems, Inc. (Siemens Healthineers AG)
- AngioDynamics, Inc.
- Medtronic PLC
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Terumo Corporation
- Emblation Limited
- HUBER+SUHNER AG
- MedWaves, Inc.
- SympleSurgical, Inc.
- Mermaid Medical Group
Methodology
LOADING...
